reference/30805848

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30805848

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, U.S. Gov't, Non-P.H.S.\|Research Support, U.S. Gov't, P.H.S.
endingPage	1884
issn	1476-5594 0950-9232
issueIdentifier	10
pageRange	1874-1884
publicationName	Oncogene
startingPage	1874
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ba606ec1b5d14ed8f696fb32663a05f8
bibliographicCitation	Farhana L, Dawson MI, Huang Y, Zhang Y, Rishi AK, Reddy KB, Freeman RS, Fontana JA. Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activities. Oncogene. 2004 Mar 11;23(10):1874–84. doi: 10.1038/sj.onc.1207311. PMID: 14981538.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d4d0059374f1c415d372e1f7573ea85 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a371b2bd3a9ea85fd64fb6b4e81033da http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8f407934e83f3443a58d6a3d3a82629 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5a8024480170afb20ea6e4cf911b38d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_408b231b42e392fae3198ba7ffcc29f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91a27d48a3ab96ad2ef928153cb7abb2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c341988e8599008a45820ebade28cd23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dea432a74e403be0d1d3166600ed743f
date	2004-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/sj.onc.1207311 https://pubmed.ncbi.nlm.nih.gov/14981538
isPartOf	https://portal.issn.org/resource/ISSN/0950-9232 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6325 https://portal.issn.org/resource/ISSN/1476-5594
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activities
discusses	http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0458208 http://id.nlm.nih.gov/mesh/M0017909 http://id.nlm.nih.gov/mesh/M0000336 http://id.nlm.nih.gov/mesh/M0026339 http://id.nlm.nih.gov/mesh/M0283972 http://id.nlm.nih.gov/mesh/M0004490 http://id.nlm.nih.gov/mesh/M0150739 http://id.nlm.nih.gov/mesh/M0018641
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_912fcc688c4f919d88c6bda555ba6cc3 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_78edc8e186d4ca89a5d99640d0f188ad http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1ead7c33b9da755ef9e3570836b2cdf3 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.1.137 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9476 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_de0ab57f8efe995f2b0101dc926ae57f http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9866186 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2831ba64de5ff31920ec562d0963e3a4 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.11.1 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643960 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7cda3b3d1627ed9fd078d1fc2f1f23fa http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b3d8091c8ef30ad85a86ba97dd15e674 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6288 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5951 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128850736 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127476202 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128643942 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246740869

Total number of triples: 62.